Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in ANIX — Anixa Biosciences Inc

CIK 1214717 BOSTON, MA
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,005,742
+$64,737 QoQ
Shares Held
359,194
-1.5% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 62 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ANIX ranks #319 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in ANIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,005,742 359,194
2026-03-31 $941,005 364,731
2025-12-31 $1,094,854 350,915
2025-09-30 $1,134,024 343,644
2025-06-30 $1,131,358 342,836
2025-03-31 $973,157 340,265
2024-12-31 $764,154 329,377
2024-09-30 $1,035,650 328,778
2024-06-30 $730,570 330,575
2024-03-31 $998,861 320,148
2023-12-31 $1,212,391 312,472
2023-09-30 $979,842 299,646
2023-06-30 $969,657 303,018
2023-03-31 $1,179,442 274,289
2022-12-31 $1,165,728 274,289
2022-09-30 $1,331,661 270,663
2022-06-30 $826,209 270,003
2022-03-31 $737,673 269,224
2021-12-31 $783,934 263,951
2021-09-30 $1,259,046 263,951
2021-06-30 $829,559 213,804
2021-03-31 $790,723 168,958
2020-12-31 $343,241 111,805
2020-09-30 $249,043 102,487
2020-06-30 $313,610 102,487
2020-03-31 $162,954 102,487